Ion Channels as Pharmacotherapy Targets
Many drugs alter the permeability of cell membranes to ions by acting as blockers or activators of specific channels.
- Sodium channel blockers. These prevent sodium ions from entering the cell, halting membrane depolarization. This is the primary mechanism of action for local anesthetics. This group also includes antiarrhythmics (quinidine, lidocaine, procainamide) and antiepileptic drugs (phenytoin, carbamazepine), whose anticonvulsant activity is specifically linked to the blockade of these structures.
- Calcium channel blockers. Calcium ions are critical for muscle contraction, impulse generation in the sinus node, conduction of excitation, and platelet aggregation. Medications (nifedipine, verapamil) block slow calcium channels, preventing calcium influx into the cell. The result is vascular smooth muscle relaxation, decreased heart rate, and suppression of atrioventricular conduction. They are used for hypertension, angina, and arrhythmias.
- Potassium channel modulators. Activators are actively used in this group (e.g., minoxidil, diazoxide). They stimulate the efflux of potassium ions from the cell, causing membrane hyperpolarization. This leads to reduced vascular tone and lowered blood pressure.
Enzymes and Transport Systems
Pharmacological action on enzymes generally consists of their inhibition (suppression of activity), which alters the concentration of important endogenous substances in the body.
- Monoamine oxidase (MAO) inhibitors. These block the enzyme that degrades catecholamines. This leads to the accumulation of serotonin, dopamine, and norepinephrine in the CNS (used as antidepressants, e.g., nialamide).
- Nonsteroidal anti-inflammatory drugs (NSAIDs). Their target is the cyclooxygenase enzyme. Suppressing its activity decreases prostaglandin synthesis, providing a potent anti-inflammatory effect.
- Anticholinesterase agents. These block the enzyme acetylcholinesterase, halting the breakdown of acetylcholine. The accumulation of this neurotransmitter in the synaptic cleft increases the tone of skeletal muscle and smooth muscle organs (gastrointestinal tract, urinary bladder).
Transport systems also serve as important targets. Drugs bind to carrier proteins or ion pumps:
- Tricyclic antidepressants block presynaptic membrane transport proteins, disrupting the reuptake of norepinephrine and serotonin.
- Cardiac glycosides block the ion pump ($Na^+/K^+$-ATPase) in cardiomyocytes, disrupting transmembrane ion exchange.
Structural Proteins and Extracellular Mechanisms
Some medications act on the cellular cytoskeleton. For example, the target for antineoplastic agents (vinca alkaloids) is the structural protein tubulin. These drugs bind to its monomers, preventing microtubule assembly. This produces an antimitotic effect—malignant cells lose their ability to divide.
There is also chemical interaction, where the effect is achieved through direct extracellular reactions rather than via receptors. A classic example is antacids. They simply neutralize excess hydrochloric acid in the stomach chemically, which helps with hyperacid gastritis and peptic ulcer disease.
Finally, a number of agents lack specific biological targets altogether, working exclusively based on their physicochemical properties. The osmotic diuretic mannitol increases osmotic pressure in the renal tubules. Water stops being reabsorbed, is retained within the tubular lumen, and diuresis increases significantly.